BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2023 3:41:16 PM | Browse: 417 | Download: 979
 |
Received |
|
2022-12-04 09:44 |
|
Peer-Review Started |
|
2022-12-04 09:45 |
|
First Decision by Editorial Office Director |
|
2022-12-26 08:40 |
|
Return for Revision |
|
2022-12-26 08:40 |
|
Revised |
|
2022-12-30 01:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-03-01 03:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-03-07 18:50 |
|
Articles in Press |
|
2023-03-07 18:50 |
|
Edit the Manuscript by Language Editor |
|
2023-02-05 20:29 |
|
Typeset the Manuscript |
|
2023-03-09 10:36 |
|
Publish the Manuscript Online |
|
2023-03-15 15:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Alexandra Papadopoulou and Konstantinos I Papadopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos I Papadopoulos, MD, PhD, Chief Doctor, Chief Physician, Director, Director, Research and Development , THAI StemLife Co., Ltd. , 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Wangthonglang, , Thailand, Bangkok 10310, Bangkok, Thailand. kostas@thaistemlife.co.th |
| Key Words |
Type 1 diabetes mellitus; Type 2 diabetes mellitus; Human umbilical cord mesenchymal stem cells; Diabetes remission; Diabetes reversal; Lifestyle modifications. |
| Core Tip |
The role of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus (T2DM) could at best be seen as supportive to the irreplaceable role of consistent lifestyle modifications that, at a minimum, must include nutritional and exercise interventions. Combination of newer pharmacological treatments in T2DM, such as semaglutide or tirzepatide, with cellular components is worth exploring. |
| Publish Date |
2023-03-15 15:41 |
| Citation |
Papadopoulou A, Papadopoulos KI. Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus. World J Diabetes 2023; 14(3): 347-351 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i3/347.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i3.347 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
